Cormorant Asset Management, LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Cormorant Asset Management, LP held in its portfolio 35 assets valued at $2,162,580,277 (i.e. $2.16B).
The most valuable assets in the portfolio included: PRAXIS PRECISION MEDICINES I ($280.00M), BRIDGEBIO ONCOLOGY THERAPEUT ($223.84M), and ABIVAX SA ($182.05M).
The chart below shows the top 10 valuable assets, and the table below shows the top 35 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Cormorant Asset Management, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 950000 | 280003000 | COM NEW |
| BRIDGEBIO ONCOLOGY THERAPEUT | 17878594 | 223839997 | COM NEW |
| ABIVAX SA | 1350000 | 182054250 | SPONSORED ADS |
| INVESCO QQQ TR | 250000 | 153577500 | UNIT SER 1 |
| EYEPOINT INC | 8265000 | 151001550 | COM NEW |
| ISHARES TR | 500000 | 123080000 | RUSSELL 2000 ETF |
| SPDR SERIES TRUST | 1000000 | 121930000 | STATE STREET SPD |
| RAPPORT THERAPEUTICS INC | 3027521 | 91854987 | COM |
| BRIDGEBIO PHARMA INC | 1200000 | 91788000 | COM |
| BRIGHT MINDS BIOSCIENCES INC | 1059331 | 82670191 | COM NEW |
| EDGEWISE THERAPEUTICS INC | 3285000 | 81517275 | COM |
| OLEMA PHARMACEUTICALS INC | 2750000 | 68750000 | COM |
| MOONLAKE IMMUNOTHERAPEUTICS | 4355433 | 57404607 | CLASS A ORD |
| INSMED INC | 275000 | 47861000 | COM PAR $.01 |
| ENGENE HOLDINGS INC | 4000000 | 36120000 | COM |
| ALUMIS INC | 3635596 | 35483417 | COM |
| MBX BIOSCIENCES INC | 1120000 | 35324800 | COM |
| NEWAMSTERDAM PHARMA COMPANY | 1000000 | 35080000 | ORDINARY SHARES |
| CENTESSA PHARMACEUTICALS PLC | 1325000 | 33138250 | SPONSORED ADS |
| PHARVARIS N V | 1083000 | 30053250 | COM |
| BIOAGE LABS INC | 2040605 | 26997204 | COM |
| ASCENDIS PHARMA A/S | 100000 | 21324000 | SPONSORED ADR |
| TARSUS PHARMACEUTICALS INC | 250000 | 20470000 | COM |
| CORBUS PHARMACEUTICALS HLDGS | 2344971 | 19088064 | COM NEW |
| GH RESEARCH PLC | 1300000 | 16510000 | ORDINARY SHARES |
| ORUKA THERAPEUTICS INC | 533340 | 16165535 | COM |
| ARCUTIS BIOTHERAPEUTICS INC | 500000 | 14520000 | COM |
| CRINETICS PHARMACEUTICALS IN | 300000 | 13965000 | COM |
| AXSOME THERAPEUTICS INC | 75000 | 13698000 | COM |
| CABALETTA BIO INC | 4400000 | 9636000 | COM |
| JANUX THERAPEUTICS INC | 650000 | 8970000 | COM |
| COGENT BIOSCIENCES INC | 225000 | 7992000 | COM |
| VAXCYTE INC | 125000 | 5767500 | COM |
| AMYLYX PHARMACEUTICALS INC | 400000 | 4832000 | COM |
| BIOHAVEN LTD | 10000 | 112900 | COM |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.